These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 26304086)

  • 1. [Flow cytometric test using eosin-5'-maleimide (EMA) labelling of red blood for diagnosis of hereditary spherocytosis].
    Wang J; Zheng B; Zhao Y; Chen X; Liu Y; Bo L; Zheng Y; Zhang F; Ru K; Wang H
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jul; 36(7):598-601. PubMed ID: 26304086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric osmotic fragility test and eosin-5'-maleimide dye-binding tests are better than conventional osmotic fragility tests for the diagnosis of hereditary spherocytosis.
    Arora RD; Dass J; Maydeo S; Arya V; Radhakrishnan N; Sachdeva A; Kotwal J; Bhargava M
    Int J Lab Hematol; 2018 Jun; 40(3):335-342. PubMed ID: 29573337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison study of the eosin-5'-maleimide binding test, flow cytometric osmotic fragility test, and cryohemolysis test in the diagnosis of hereditary spherocytosis.
    Park SH; Park CJ; Lee BR; Cho YU; Jang S; Kim N; Koh KN; Im HJ; Seo JJ; Park ES; Lee JW; Yoo KH; Jung HL
    Am J Clin Pathol; 2014 Oct; 142(4):474-84. PubMed ID: 25239414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delay in the measurement of eosin-5′-maleimide (EMA) binding does not affect the test result for the diagnosis of hereditary spherocytosis.
    Ciepiela O; Kotuła I; Górska E; Stelmaszczyk-Emmel A; Popko K; Szmydki-Baran A; Adamowicz-Salach A; Demkow U
    Clin Chem Lab Med; 2013 Apr; 51(4):817-23. PubMed ID: 23023797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward the harmonization of result presentation for the eosin-5'-maleimide binding test in the diagnosis of hereditary spherocytosis.
    Hunt L; Greenwood D; Heimpel H; Noel N; Whiteway A; King MJ
    Cytometry B Clin Cytom; 2015 Jan; 88(1):50-7. PubMed ID: 25227211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early postnatal diagnosis of hereditary spherocytosis by combining light microscopy, acidified glycerol lysis test and eosin-5'-maleimide binding assay.
    Andres O; Eber S; Speer CP
    Ann Hematol; 2015 Dec; 94(12):1959-64. PubMed ID: 26336967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative evaluation of Eosin-5'-maleimide flow cytometry reveals a high diagnostic efficacy for hereditary spherocytosis.
    Joshi P; Aggarwal A; Jamwal M; Sachdeva MU; Bansal D; Malhotra P; Sharma P; Das R
    Int J Lab Hematol; 2016 Oct; 38(5):520-6. PubMed ID: 27339613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating eosin-5-maleimide binding as a diagnostic test for hereditary spherocytosis in newborn infants.
    Christensen RD; Agarwal AM; Nussenzveig RH; Heikal N; Liew MA; Yaish HM
    J Perinatol; 2015 May; 35(5):357-61. PubMed ID: 25357094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic power of laboratory tests for hereditary spherocytosis: a comparison study in 150 patients grouped according to molecular and clinical characteristics.
    Bianchi P; Fermo E; Vercellati C; Marcello AP; Porretti L; Cortelezzi A; Barcellini W; Zanella A
    Haematologica; 2012 Apr; 97(4):516-23. PubMed ID: 22058213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hereditary spherocytosis diagnosed with the eosin-5'-maleimide binding test.
    Watanabe T; Ono H; Tajima I; Ishigaki H; Hakamata A; Shirai M; Endoh A; Hongo T
    Pediatr Int; 2014 Jun; 56(3):427-9. PubMed ID: 24894931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with eosin-5'-maleimide as a diagnostic tool for red cell membrane cytoskeleton disorders.
    Kedar PS; Colah RB; Kulkarni S; Ghosh K; Mohanty D
    Clin Lab Haematol; 2003 Dec; 25(6):373-6. PubMed ID: 14641141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [THE CYTOMETRIC TECHNIQUE OF BINDING OF EOSIN-5-MALEIMIDE IN DIAGNOSTIC OF INHERENT SPHEROCYTOSIS].
    Kuzminova JA; Plyasunova SA; Jogov VV; Smetanina NS
    Klin Lab Diagn; 2016 Mar; 61(3):168-72. PubMed ID: 27506108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of eosin-5-maleimide flow cytometric test in diagnosis of hereditary spherocytosis.
    Kar R; Mishra P; Pati HP
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 2):8-16. PubMed ID: 18782334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of a modified flow cytometry osmotic fragility test with the classical method for the diagnosis of hereditary spherocytosis.
    Shahal-Zimra Y; Nosgorodcky Y; Eshel E; Rotem Z; Ross L; Pickholtz I; Rabizadeh E; Chezar J
    Cytometry B Clin Cytom; 2022 Sep; 102(5):377-383. PubMed ID: 34528390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical, Cellular, and Proteomic Characterization of Hereditary Spherocytosis Among Tunisians.
    Trabelsi N; Bouguerra G; Haddad F; Ouederni M; Darragi I; Boudrigua I; Chaouachi D; Barmat M; Fouzai C; Bejaoui M; Menif S; Kraiem I; Abbes S
    Cell Physiol Biochem; 2021 Mar; 55(1):117-129. PubMed ID: 33667330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometry as a diagnostic tool for hereditary spherocytosis.
    Stoya G; Gruhn B; Vogelsang H; Baumann E; Linss W
    Acta Haematol; 2006; 116(3):186-91. PubMed ID: 17016037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eosin-5-maleimide binding to band 3 and Rh-related proteins forms the basis of a screening test for hereditary spherocytosis.
    King MJ; Smythe JS; Mushens R
    Br J Haematol; 2004 Jan; 124(1):106-13. PubMed ID: 14675415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using the eosin-5-maleimide binding test in the differential diagnosis of hereditary spherocytosis and hereditary pyropoikilocytosis.
    King MJ; Telfer P; MacKinnon H; Langabeer L; McMahon C; Darbyshire P; Dhermy D
    Cytometry B Clin Cytom; 2008 Jul; 74(4):244-50. PubMed ID: 18454487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Flowcytometric diagnostics of hereditary spherocytosis].
    Riley CH; Nikolajsen K; Kjaersgaard E; Klausen TW; Mourits-Andersen T; Clausen N; Lausen B; Rosthøj S; Birgens H
    Ugeskr Laeger; 2009 Nov; 171(49):3610-4. PubMed ID: 19954702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of capillary blood to diagnose hereditary spherocytosis.
    Crisp RL; Solari L; Gammella D; Schvartzman GA; Rapetti MC; Donato H
    Pediatr Blood Cancer; 2012 Dec; 59(7):1299-301. PubMed ID: 22488885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.